A new gene therapy reversed heart failure in pigs by repairing heart function through cBIN1, showing major promise for future ...

New Gene Therapy Reverses Heart Failure in Large Animal Model Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart ...

Bayer’s AskBio unit has reported the first clinical data for its congestive heart failure gene therapy ... the current standard of care does not reverse the trajectory of the disease to ultimate ...

The treatment, which could take only 30 minutes, increases blood flow through parts of the heart damaged by attacks or clogged by fat. Patients with severe coronary heart disease, whom doctors ...

Nuevocor Pte. Ltd. has closed a $45 million series B, enabling it to move lead gene therapy NVC-001 into the clinic in the treatment of an inherited form of cardiomyopathy. BioWorld Science Science ...

A research team has developed and safely delivered a personalized gene editing therapy to treat an infant with a life-threatening, incurable genetic disease. The infant, who was diagnosed with the ...

In a historic medical breakthrough, a child diagnosed with a rare genetic disorder has been successfully treated with a ...

Nuevocor is developing a one-time gene therapy for heart failure patients. Inovio taking on Covid again, almost 3 years after abandoning vaccine CEO says biotech firm is on path to $1B in revenue ...

Nuevocor Pte. Ltd. has closed a $45 million series B, enabling it to move lead gene therapy NVC-001 into the clinic in the treatment of an inherited form of cardiomyopathy.